Laryngeal Diseases

5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Narrower: Laryngostenosis 1

Treatments and conditions

Laryngeal Diseases
Treatment and conditionWhere it standsTrials
Curcumin for laryngostenosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Petosemtamab for laryngeal diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy + Volume Modulated Arc Therapy + NIVOLUMAB + IPILIMUMAB for laryngeal diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VMD-928 100 mg Tablet for laryngeal diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VMD-928 Tablet and Pembrolizumab (200 mg) for laryngeal diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.